NCT01314911: A trial that was reported late by National Institute of Allergy and Infectious Diseases (NIAID)
This trial has reported, although it was 54 days late in doing so.
Full data
| Full entry on ClinicalTrials.gov | NCT01314911 |
|---|---|
| Title | A Randomized Double-Blind Study Comparing Oseltamivir Versus Placebo for the Treatment of Influenza in Low Risk Adults |
| Results Status | Reported (late) |
| ACT or pACT? | This is what FDAAA officially calls a "probable Applicable Clinical Trial" |
| Start date | April 30, 2011 |
| Completion date | Nov. 18, 2017 |
| Required reporting date | Nov. 18, 2018, midnight |
| Actual reporting date | Jan. 11, 2019 |
| Date last checked at ClinicalTrials.gov | March 28, 2025 |
| Days late | 54 |